{"id":"W4399564759","doi":"10.1136/bmjonc-2023-000181","title":"Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial","year":2024,"lang":"en","type":"article","venue":"BMJ Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Genentech; Medac; Ipsen; National Institutes of Health; Shionogi; Ono Pharmaceutical; Astellas Pharma; Eisai; Chugai Pharmaceutical; Seagen; National Cancer Institute; Intuitive Surgical; Calithera Biosciences; Incyte; Pfizer; GlaxoSmithKline; Arrowhead Pharmaceuticals; PTC Therapeutics; Sanofi; Exelixis; Genomic Health; Les Laboratories Pierre Fabre; AstraZeneca; Bristol-Myers Squibb","keywords":"Avelumab; Medicine; Sunitinib; Renal cell carcinoma; Axitinib; Post-hoc analysis; Internal medicine; Eosinophil; Oncology; Nivolumab; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004185567,0.0004281345,0.001088044,0.0002858695,0.0001340763,0.00007629276,0.000157697,0.0002489217,0.0000877245],"category_scores_gemma":[0.0003296242,0.0002304929,0.0001176397,0.0005461049,0.0001071931,0.0001225386,0.00009450434,0.0005263035,0.00003597571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001276074,"about_ca_system_score_gemma":0.001212628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006609532,"about_ca_topic_score_gemma":0.001262835,"domain_scores_codex":[0.9968858,0.0004876584,0.0007474512,0.000713145,0.0006570641,0.0005088391],"domain_scores_gemma":[0.9963297,0.002383846,0.000335493,0.0004334103,0.0002805333,0.0002369638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2885731,0.001542212,0.6775984,0.0001089367,0.001736672,0.002499702,0.004178338,0.0003230358,0.001365249,0.00001930077,0.001761113,0.02029395],"study_design_scores_gemma":[0.09836077,0.02167963,0.8758557,0.000153521,0.001386189,0.00001751976,0.0002607021,0.00003856032,0.0008439121,0.00000718039,0.001112803,0.0002835409],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893504,0.0002430639,0.00003947703,0.005663014,0.0001973657,0.003751611,0.0002679109,0.00006160284,0.0004255892],"genre_scores_gemma":[0.9954824,0.00001357477,0.00139187,0.0005575665,0.0006015537,0.0002683459,0.0008917655,0.00006421101,0.0007286426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1982573,"threshold_uncertainty_score":0.9399226,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04883230815604549,"score_gpt":0.3487168361763055,"score_spread":0.29988452802026,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}